deltatrials
Suspended PHASE1 INTERVENTIONAL 1-arm NCT02452385

Phase 1 Study of CM082 in Patients With wAMD

Phase 1 Study of CM082 in Patients With wAMD: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy

Sponsor: AnewPharma

Conditions Age-Related Macular Degeneration
Interventions CM082 tablet
Updated 9 times since 2017 Last updated: Jan 8, 2020 Started: Mar 31, 2015 Primary completion: Jun 30, 2020 Completion: Jun 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Sponsor requirements

Listed as NCT02452385, this PHASE1 trial focuses on Age-Related Macular Degeneration and remains suspended. Sponsored by AnewPharma, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jan 2018 · 12 months · monthly snapshotActive Not Recruiting~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotActive Not Recruiting~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshotActive Not Recruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotSuspended~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotSuspended~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotSuspended~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotSuspended~Sep 2025 – present · 10 months · monthly snapshotSuspended

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Suspended PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Suspended PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Suspended PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Suspended PHASE1

  5. Feb 2020 — Jan 2021 [monthly]

    Suspended PHASE1

    Status: Active Not Recruiting → Suspended

▶ Show 4 earlier versions

  1. Aug 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1

  2. Jun 2018 — Aug 2019 [monthly]

    Active Not Recruiting PHASE1

  3. Jan 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

  4. Jan 2017 — Jan 2018 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AnewPharma
  • West China Hospital
Data source: AnewPharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations